← Eichor
Study identifier: NCT07187934 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

EVALUATION OF A FULLY AUTOMATED AI TOOL FOR EMBRYO RANKING

Condition: Pregnancy  ·  Sponsor: Universitair Ziekenhuis Brussel

PhaseNA
Planned participants1325
Who can joinFemale, 18 Years to 42 Years
Healthy volunteersYes

About this study

This study aims to investigate whether embryo ranking by a fully automated AI tool (iDAScore) results in a similar transfer-to-pregnancy compared to manual embryo ranking by an embryologist. IVF patients who are planned for a freeze-all approach (where all usable embryos are frozen and transferred in later transfer cycles) will be allocated to either the control (ranking by embryologist) or intervention arm (ranking by iDAScore). The frozen embryos will be warmed and transferred one by one, according to their assigned rank. We want to see if the average number of embryo transfers that is needed to achieve a clinical pregnancy (transfer-to-pregnancy) is similar in both groups.

This description comes directly from the study's public registry record.

Talk to the study team

Elsie Nulens  ·  +32 2 477 66 48  ·  elsie.nulens@uzbrussel.be

Tine Bosman, Msc  ·  +3224774049  ·  tine.bosman@uzbrussel.be

Always discuss trial participation with your own doctor first.

Locations (1)

Brussels IVF, UZ BrusselBrussels, Brussels Capital, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07187934